What Is Melanotan 2?
Melanotan 2 research has generated extensive interest across melanocortin system biology, appetite regulation, CNS neuroscience, and pigmentation research — as the original pan-melanocortin receptor agonist and the parent compound from which both Melanotan 1 and PT-141 were derived, it remains the most broadly active melanocortin research tool available and a foundational compound in understanding the full scope of melanocortin receptor biology.
Melanotan 2 (MT-II, cyclo-[Nle4, D-Phe7]-α-MSH, molecular weight approximately 1,024 Da) is a synthetic cyclic analogue of alpha-melanocyte stimulating hormone (α-MSH), developed at the University of Arizona by Mac Hadley and Victor Hruby — the same group responsible for Melanotan 1. The critical structural innovation in MT-II is cyclization through a lactam bridge between the lysine at position 5 and aspartate at position 10 — this cyclic constraint locks the peptide in a bioactive β-turn conformation that simultaneously increases receptor binding affinity, metabolic stability, and — critically — generates a receptor binding profile dramatically different from the linear Melanotan 1. While Melanotan 1 is selective for MC1R, MT-II’s cyclic structure confers high-affinity binding at MC1R, MC3R, MC4R, and MC5R — making it a pan-melanocortin agonist that activates the entire melanocortin receptor system simultaneously. This broad receptor activity profile is both MT-II’s greatest research utility (allowing whole-system melanocortin research) and its greatest limitation (precluding receptor-specific mechanistic attribution without careful comparative design).
Mechanism of Action
Pan-Melanocortin Receptor Agonism
Melanotan 2 binds with high affinity to MC1R, MC3R, MC4R, and MC5R — the four melanocortin receptor subtypes expressed in peripherally accessible tissues and the CNS. MC2R (the ACTH receptor expressed exclusively in the adrenal cortex) shows minimal MT-II binding, maintaining the specificity of the stress axis from non-specific melanocortin peptide activation. All four MT-II-responsive receptors couple to Gs proteins and signal primarily through adenylyl cyclase activation and cAMP elevation, but their distinct anatomical distribution, coactivator environments, and downstream effector coupling produce dramatically different biological outputs from the same receptor-level signal.
MC1R-Mediated Melanogenesis
Through MC1R agonism in melanocytes, MT-II drives the same eumelanin synthesis cascade as Melanotan 1 — MC1R → Gs → cAMP → PKA → CREB → MITF → tyrosinase/TYRP1/DCT expression → eumelanin production. This melanogenic activity is the most immediately visible biological effect of MT-II administration and was the original intended research application. However, MT-II’s concurrent activation of MC3R, MC4R, and MC5R produces simultaneous CNS and peripheral effects that are absent with the MC1R-selective Melanotan 1 — making comparative MT-II/MT-1 research designs essential for attributing melanogenesis-independent effects to specific receptor subtypes.
MC4R-Mediated CNS Effects
MC4R in the hypothalamus and limbic system is the primary mediator of MT-II’s CNS effects — including appetite suppression through PVN MC4R activation, energy expenditure promotion, and the arousal-related effects that led to the discovery of PT-141 as an MT-II metabolite. MC4R-deficient mice develop severe hyperphagia and obesity — establishing MC4R as a critical energy balance regulator — and MT-II’s MC4R agonism produces robust appetite suppression in preclinical models. The CNS arousal effects of MT-II are mediated through the same MC3R/MC4R circuits studied with PT-141, but MT-II’s concurrent melanogenesis makes receptor-specific attribution more complex.
MC3R and MC5R Activity
MC3R is expressed in the hypothalamus, limbic system, and peripheral tissues, where it regulates energy balance through complementary but distinct mechanisms from MC4R — including modulation of energy intake and partitioning between storage and utilization. MC5R is expressed predominantly in exocrine glands (sebaceous, lacrimal, preputial) and modulates glandular secretion. MT-II’s activity at both receptors adds physiological dimensions to research designs that are absent with MC1R-selective or MC3R/MC4R-selective compounds — including exocrine gland function modulation and distinct MC3R-mediated metabolic contributions.
Autonomic and Cardiovascular Effects
MC4R expressed in brainstem cardiovascular centers and spinal autonomic nuclei mediates melanocortin effects on heart rate, blood pressure, and pelvic autonomic function. MT-II-induced autonomic effects — including the transient blood pressure changes and nausea observed in early clinical research — reflect MC4R activation in these autonomic regulatory centers and represent important pharmacological considerations in research design, particularly when comparing MT-II to more selective melanocortin compounds.
Research Applications
Melanocortin System Pharmacology Research
The most fundamental research application for Melanotan 2 is as the pan-melanocortin reference agonist — activating all accessible melanocortin receptors simultaneously to establish the full pharmacological scope of melanocortin system activation. Comparison of MT-II responses with those of receptor-selective compounds (Melanotan 1 for MC1R, PT-141 for MC3R/MC4R) allows systematic receptor subtraction studies — identifying which components of the MT-II response are attributable to each receptor subtype. This comparative approach has been essential for establishing the mechanistic pharmacology of the melanocortin system and for identifying receptor-selective compounds suitable for clinical development.
Appetite and Energy Balance Research
MT-II’s potent MC4R-mediated appetite suppression has made it a primary research tool in obesity and energy balance research — used to investigate MC4R’s role in energy homeostasis, establish the pharmacology of hypothalamic melanocortin circuits, and probe the downstream effectors of MC4R activation in appetite-regulating neurons. Research has used MT-II alongside MC4R-selective compounds and MC4R knockout models to map the neural circuits underlying melanocortin-driven appetite suppression and energy expenditure enhancement.
Pigmentation Biology Research
MT-II’s MC1R-mediated melanogenesis has been studied extensively in the context of UV protection, melanoma biology, and the relationship between pigmentation genotype (MC1R variants) and photocarcinogenesis risk. Comparative studies using MT-II and Melanotan 1 allow isolation of MC1R-specific versus non-MC1R contributions to observed pigmentation effects — important for mechanistic attribution in complex in vivo systems where multiple receptor subtypes are co-activated.
CNS Arousal and Motivational Research
The discovery of PT-141 as an MT-II metabolite emerged from research on MT-II’s CNS arousal effects — establishing the melanocortin system as a regulator of arousal-related motivational behaviors. MT-II research in CNS arousal models preceded and informed all subsequent PT-141 research, and continues as a reference standard for understanding the pharmacological scope of CNS melanocortin activation beyond the MC3R/MC4R-selective profile of PT-141.
Exocrine Gland and MC5R Research
MC5R’s restricted expression in exocrine glands makes MT-II one of the few systemically available tools for studying MC5R biology — including its roles in sebaceous gland lipid secretion (relevant to acne and skin biology), lacrimal gland function (relevant to dry eye disease), and other exocrine secretory functions. Research using MT-II in comparison with MC5R-selective compounds or MC5R knockout models has helped establish the physiological significance of this poorly understood melanocortin receptor subtype.
Melanotan 2 in the AminoForge Melanocortin Research Catalog
Melanotan 2 is the pan-melanocortin reference standard in AminoForge’s melanocortin research catalog. Its research value is maximized through comparison with receptor-selective compounds: Melanotan 1 provides MC1R-selective melanogenesis and photoprotection research without CNS or appetite effects, while PT-141 provides MC3R/MC4R-selective CNS arousal research without peripheral melanogenesis. Parallel research designs using all three compounds enable systematic receptor subtraction analysis across the melanocortin system. For researchers extending melanocortin research into skin biology, GHK-Cu offers complementary collagen synthesis and skin repair mechanisms. For further reading see: Melanotan 2 melanocortin receptor pharmacology and biological profile (PubMed).
Shop Melanotan 2 at AminoForge — ≥99% purity, third-party COA verified, USA manufactured, ships within 48 hours.
Formulation and Storage
Melanotan 2 is available as a lyophilized powder. With a molecular weight of approximately 1,024 Da and a cyclic lactam bridge structure, MT-II has enhanced metabolic stability compared to linear α-MSH — the cyclic constraint significantly reduces endopeptidase susceptibility. Standard storage at −20°C for lyophilized powder applies, with reconstituted solutions stored at 2–8°C and protected from light. Bacteriostatic water is the standard reconstitution vehicle. Research-grade purity should be verified at ≥99% by HPLC with mass spectrometry confirmation of the 1,024 Da molecular weight and the cyclic lactam structure.
All products sold by AminoForge are intended exclusively for laboratory and research purposes. Not for human or veterinary consumption. Researchers are responsible for compliance with all applicable laws and regulations governing research compound use in their jurisdiction.